XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 1,989 shares, a drop of 28.8% from the December 31st total of 2,794 shares. Based on an average daily volume of 1,351 shares, the days-to-cover ratio is presently 1.5 days. Based on an average daily volume of 1,351 shares, the days-to-cover ratio is presently 1.5 days.
XOMA Stock Performance
Shares of XOMAP opened at $26.15 on Friday. The company’s 50 day simple moving average is $26.61 and its 200-day simple moving average is $26.35. XOMA has a 12-month low of $24.96 and a 12-month high of $30.00.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
See Also
- Five stocks we like better than XOMA
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
